![]()
MIRA INFORM
REPORT
|
Report Date : |
08.01.2011 |
IDENTIFICATION DETAILS
|
Name : |
ESPEE BIOPHARMA & FINECHEM LLC |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
21.04.2009 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Pharmaceutical ingredients
and healthcare products manufacturer and supplier |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment
Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
POLITICAL DATA |
ECONOMIC DATA |
|
Form of Government: Federal
|
Currency: USD |
|
Ordered as: |
Espee Biopharma & Finechem LLC |
||
|
Address in the order: |
|
||
|
|
|
||
|
Legal Name: |
Espee Biopharma & Finechem LLC |
||
|
|
|
||
|
Legal Address |
|
||
|
Operative Address |
|
||
|
Telephone: |
(888) 851-6667 / (201) 253-9053 |
ID : |
4679062 |
|
Fax: |
(888) 317-5667 |
Legal Form: |
Limited Liability Company |
|
Email: |
Registered in: |
|
|
|
Website: |
Date Created: |
1985 |
|
|
Manager: |
Mr. Ravi Patel, President |
Date Incorporated: |
April, 21st. 2009 |
|
Staff: |
20 |
Stock: |
NA |
|
|
|
Value: |
NA |
|
Activity: |
Pharmaceutical ingredients and healthcare products manufacturer and
supplier |
||
|
HISTORY |
|
|
|
The company was created in 1985 |
|
PRINCIPAL ACTIVITY |
|
|
|
Pharmaceutical ingredients and healthcare products manufacturer and
supplier |
|
Products/Services description: |
|
|
|
Their business range includes APIs, non APIs, pharmaceutical
intermediates, dyes and dye intermediates, fine chemicals and raw materials, psyllium
products, health care products and contract manufacturing. Their active pharmaceutical ingredients include ranitidine, and
sucralose. They also offer services such as custom manufacturing,
warehouse-distribution, regulatory compliance and new product development. The company was incorporated in |
|
Sales are: |
|
|
|
Wholesale |
|
Clients: |
|
|
|
Professionals of the industry |
|
Suppliers: |
|
|
|
- USFDA - WHO - GMP - ISO Standards (Among others) |
|
Operations area: |
|
|
|
National, International |
|
The subject employs 20 employee(s) |
|
|
LOCATION |
|
|
Headquarters |
|
|
|
The legal address of the company is that of the registran officer: However, it is headquartered at: |
|
Listed at the stock exchange: |
|
|
|
NO |
|
Shareholders Parent Company(ies): |
|
|
|
This is a private company. |
|
Management: |
|
|
|
|
|
Related Companies: |
|
|
|
Espee Wellness Espee Dyes & Chemicals Espee Drugs |
|
As a private company the subject does not publish any financial
statements. |
|
We have contacted Mr. Ravi Patel, who
refused to provide us any financial data without knowing the name of the
inquiring party. |
|
Legal Fillings |
|
There
are no UCC** files listed with the Secretary of State of Illinois. There are no legal filings listed with the
District Court. THE COMPANY IS NOT LISTED ON THE OFAC
LIST.* For information: * The Specially Designated Nationals (SDN)
List is a publication of OFAC which lists individuals and organizations with
whom ** The Uniform Commercial Code (UCC) is
one of a number of uniform acts that have been promulgated in conjunction
with efforts to harmonize the law of sales and other commercial transactions
in all 50 states within the The UCC deals primarily with transactions
involving personal property (movable property), not real property (immovable
property). It allows a creditor to notify other
creditors about a debtor’s assets used as collateral for a secured
transaction by filing a public notice (financing statement) with a particular
filing office. The Uniform Commercial Code Bureau files
and maintains on financial obligations (including IRS liens) incurred by
individuals (in business as a sole proprietor), business entities and
corporations. |
|
Local credit bureau gave a Correct credit
rate. The company is in Good Standing. This
means that all local and federal taxes were paid on due date. |
|
|
Final Opinion |
|
|
|
This is a small sized American company
which employs 20 people and has 25 years of experience in the market. We don't have any financial information on
the company, nor do we have any payments experience. We suggest working with guarantees. |
|
|
|
||
|
Profitability |
N.A. |
Public Records |
NO |
|
Indebtedness |
N.A. |
Payments |
N.A. |
|
Cash |
N.A. |
|
|
|
Person Interviewed |
|
|
|
Mr. Ravi Patel |
|
Position |
|
|
|
President |
|
Comments |
|
|
|
The person contacted refused to provide us any information on grounds of
confidentiality. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.37 |
|
|
1 |
Rs.70.38 |
|
Euro |
1 |
Rs.58.93 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.